OncoSec Medical Inc (NASDAQ:ONCS) – Equities research analysts at Piper Jaffray Companies lowered their Q2 2020 earnings per share estimates for OncoSec Medical in a report released on Monday, December 16th, Zacks Investment Research reports. Piper Jaffray Companies analyst E. Tenthoff now anticipates that the biotechnology company will post earnings per share of ($0.91) for the quarter, down from their prior estimate of ($0.79). Piper Jaffray Companies also issued estimates for OncoSec Medical’s Q3 2020 earnings at ($0.76) EPS, FY2020 earnings at ($3.39) EPS, Q1 2021 earnings at ($0.81) EPS, Q2 2021 earnings at ($0.86) EPS, Q3 2021 earnings at ($0.88) EPS, Q4 2021 earnings at ($0.93) EPS and FY2021 earnings at ($3.48) EPS.